Sagimet Biosciences Ownership | Who Owns Sagimet Biosciences?

Sagimet Biosciences Ownership Summary

Sagimet Biosciences is owned by 41.15% institutional investors, 3.50% insiders, and 55.36% retail investors. Vanguard group is the largest institutional shareholder, holding 3.88% of SGMT shares. Federated Hermes Kaufmann Small Cap A is the top mutual fund, with 3.37% of its assets in Sagimet Biosciences shares.

SGMT Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Sagimet Biosciences	41.15%	3.50%	55.36%
Sector	Healthcare Stocks	35.56%	12.08%	52.36%
Industry	Biotech Stocks	35.43%	12.01%	52.56%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vanguard group	1.26M	3.88%	$7.46M
Woodline partners lp	1.00M	3.09%	$5.23M
Marshall wace, llp	966.25K	2.99%	$5.04M
Baker bros. advisors lp	953.00K	2.95%	$4.98M
Affinity asset advisors	868.02K	2.68%	$4.54M
Millennium management	862.30K	2.67%	$4.51M
Blackrock funding, inc. /de	799.94K	2.47%	$4.18M
Hhlr advisors	724.80K	2.24%	$3.79M
Renaissance	625.47K	1.93%	$3.27M
Schonfeld strategic advisors	523.77K	1.63%	$3.59M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Blue owl capital lp	333.88K	0.47%	$1.74M
Fny investment advisers	149.76K	0.34%	$782.00K
Affinity asset advisors	868.02K	0.23%	$4.54M
Hhlr advisors	724.80K	0.23%	$3.79M
Rb capital management	97.00K	0.11%	$506.82K
Pale fire capital se	221.88K	0.10%	$1.16M
Readystate asset management lp	325.36K	0.10%	$2.23M
Dumac	71.19K	0.05%	$371.98K
Dynamic technology lab private	47.82K	0.04%	$249.86K
683 capital management	126.35K	0.03%	$660.17K

Top Buyers

Holder	Shares	% Assets	Change
Schonfeld strategic advisors	523.77K	0.02%	430.64K
Renaissance	625.47K	0.01%	282.97K
Millennium management	862.30K	0.00%	275.36K
Marshall wace, llp	966.25K	0.01%	185.81K
Vanguard fiduciary trust	162.62K	0.00%	162.62K

Top Sellers

Holder	Shares	% Assets	Change
Nea management company	-	-	-2.00M
Alyeska investment group	-	-	-1.19M
Blue owl capital lp	333.88K	0.47%	-910.00K
Rock springs capital management lp	-	-	-787.81K
Siren	-	-	-724.77K

New Positions

Holder	Shares	% Assets	Change	Value
Vanguard fiduciary trust	162.62K	0.00%	162.62K	$849.68K
Graham capital management	49.05K	0.01%	49.05K	$336.49K
Dynamic technology lab private	47.82K	0.04%	47.82K	$249.86K
Jump financial	28.95K	0.00%	28.95K	$151.27K
Cubist systematic strategies	27.66K	0.00%	27.66K	$189.76K

Sold Out

Holder	Change
Advisor group	-10.00
Hollencrest capital management	-15.00
Farther finance advisors	-39.00
Proffitt & goodson	-175.00
Rise advisors	-306.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	91	-3.19%	13,309,109	-7.55%	41	2.09%	49	-5.77%	17	-5.56%
Dec 31, 2025	25	-67.95%	3,097,338	-75.49%	9	0.62%	12	-72.73%	4	-55.56%
Sep 30, 2025	21	-69.12%	1,885,710	-83.19%	5	0.48%	8	-77.78%	2	-77.78%
Jun 30, 2025	73	-2.67%	11,674,800	-15.26%	36	1.98%	38	15.15%	11	-38.89%
Mar 31, 2025	6	-91.43%	2,545,717	-85.38%	7	0.26%	1	-96.77%	1	-94.74%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Federated Hermes Kaufmann Small Cap A	2.08M	3.37%	2.08M
Vanguard Morn Total Stk Mkt Idx Investor	1.86M	3.01%	1.08M
Vanguard Total Stock Mkt Idx Inv	1.86M	3.01%	1.08M
iShares Russell 2000 ETF	1.47M	2.37%	-26.02K
State Street® SPDR® S&P® Biotech ETF	967.88K	1.57%	2.22K
abrdn Life Sciences Investors	847.70K	1.37%	281.59K
Vanguard Institutional Extnd Mkt Idx Tr	658.77K	1.07%	26.76K
BGF World Healthscience A2	658.27K	1.07%	658.27K
BlackRock Health Sciences Opps Inv A	585.18K	0.95%	-
iShares Biotechnology ETF	425.86K	0.69%	-1.30K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jul 20, 2026	Happel David	President & CEO	Sell	$497.07K
Jul 20, 2026	Rozek Elizabeth	Chief Legal & Admin. Officer	Sell	$81.83K
Jul 20, 2026	Kemble George	-	Sell	$140.53K
Feb 10, 2026	Happel David	President & CEO	Sell	$64.86K
Feb 10, 2026	Chauche Thierry	Chief Financial Officer	Sell	$7.03K

Insider Transactions Trends

Date	Buy	Sell
2026 Q3	-	3
2026 Q2	-	-
2026 Q1	-	4
2025 Q4	-	1
2025 Q3	-	3

SGMT Ownership FAQ

Who Owns Sagimet Biosciences?

Sagimet Biosciences shareholders are primarily institutional investors at 41.15%, followed by 3.50% insiders and 55.35% retail investors. The average institutional ownership in Sagimet Biosciences's industry, Biotech Stocks , is 35.43%, which Sagimet Biosciences exceeds.

Who owns the most shares of Sagimet Biosciences?

Sagimet Biosciences’s largest shareholders are Vanguard group (1.26M shares, 3.88%), Woodline partners lp (1M shares, 3.09%), and Marshall wace, llp (966.25K shares, 2.99%). Together, they hold 9.96% of Sagimet Biosciences’s total shares outstanding.

Does Blackrock own Sagimet Biosciences?

BlackRock is not among the top 10 institutional shareholders of Sagimet Biosciences.

Who is Sagimet Biosciences’s biggest shareholder by percentage of total assets invested?

Blue owl capital lp is Sagimet Biosciences’s biggest shareholder by percentage of total assets invested, with 0.47% of its assets in 333.88K Sagimet Biosciences shares, valued at 1.74M$.

Who is the top mutual fund holder of Sagimet Biosciences shares?

Federated Hermes Kaufmann Small Cap A is the top mutual fund holder of Sagimet Biosciences shares, with 3.37% of its total shares outstanding invested in 2.08M Sagimet Biosciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools